Skip to content

The use of Regenerating Gel in the treatment of Dental Densitivity in pediatric patients

The use of Booster and Regenerating Gel in the treatment of Dentin Hypersensitivity in pediatric patients - a randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4k2tbgd
Enrollment
246
Registered
2026-07-29
Start date
2026-05-10
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dentin Sensitivity Dental Enamel Hypomineralization

Interventions

This is a randomized, analyst-blinded study, meaning the data analysts will be unaware of the treatment groups. The volunteers will be divided into two groups, G1 and G2, which will undergo the follow
s instructions once a week for 4 weeks. Additionally, hygiene will be maintained with a standard pediatric toothpaste containing a specified concentration of fluoride (Tandy), used twice daily for 4 w

Sponsors

Faculdade São Leopoldo Mandic - Campinas
Lead Sponsor
Faculdade São Leopoldo Mandic - Campinas
Collaborator

Eligibility

Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: hildren aged 6 to 12 years; both sexes; with at least one hypersensitive molar showing a qualified response to 1-second air-blast stimuli, as defined by a score of 2 or 3 on the Schiff Cold Air Sensitivity Scale (SCASS); with a signed informed consent form

Exclusion criteria

Exclusion criteria: Patients with systemic diseases; use of long-term medication; hypersensitive study teeth with contributing etiologies not clinically recognized as associated with hypersensitivity; use of any desensitizing product within the last 6 months; ongoing treatment with antibiotics and/or anti-inflammatory drugs; presence of caries; restorations in the study teeth; allergies to: toothpaste components (minerals, phosphorus, calcium, refix technology, glycerol, xylitol, sodium lauryl sulfate, tetrasodium pyrophosphate, fluoride), oral hygiene products, test products, personal care consumer products, or their ingredients

Design outcomes

Primary

MeasureTime frame
The use of REFIX technology will not interfere with the individuals' sensitivity or quality of life.

Secondary

MeasureTime frame
Secondary outcomes are not anticipated

Countries

BR

Contacts

Public ContactJuliana Guarda

Faculdade São Leopoldo Mandic - Campinas

julianaguarda97@gmail.com+55-19-993146477

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Aug 10, 2026